Literature DB >> 9646558

[Seroprevalence versus Parvovirus B19 in blood donors].

S Muñoz1, M A Alonso, M J Fernández, J L Muñoz, J A García-Rodríguez.   

Abstract

BACKGROUND: The aim of the study was to describe the seroprevalence against Parvovirus B19 in a random sample of blood donors in the Hospital Universitario de Salamanca.
METHODS: We studied the presence of IgG and IgM antibodies against Parvovirus B19 in 136 sera from asymptomatic blood donors by enzyme immunoassay methods.
RESULTS: From 136 samples tested, 88 (64.7%) had positive absorbance values for IgG. Forty eight samples (35.5%) were negative. IgM was negative in all cases. We did not find indeterminate results. DISCUSSION: Parvovirus primoinfection usually happens in the childhood. Thus, we can expect a high percentage of general population to have antibodies against Parvovirus B19. Anti-Parvovirus B19 antibodies prevalence in blood donors was 64.7%. This failure is similar to data reported before (65%). Clinical importance of these viruses in currently related with hemathopoyesis diseases and with the possible role in theratogenesis. The presence of IgG seems to give protection except in some chronic infections recently described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646558

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  6 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.

Authors:  Helen M Faddy; Elise C Gorman; Veronica C Hoad; Francesca D Frentiu; Sarah Tozer; R L P Flower
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

Review 3.  Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.

Authors:  Mohammad Farahmand; Ahmad Tavakoli; Saied Ghorbani; Seyed Hamidreza Monavari; Seyed Jalal Kiani; Sara Minaeian
Journal:  Asian J Transfus Sci       Date:  2021-11-01

Review 4.  Parvovirus B19: What Is the Relevance in Transfusion Medicine?

Authors:  David Juhl; Holger Hennig
Journal:  Front Med (Lausanne)       Date:  2018-02-01

5.  Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank.

Authors:  Memory Chirambo-Kalolekesha; Trevor Kaile; Florence Mwaba; Victor Daka; Marah Simakando; Sumbukeni Kowa
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

6.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.